Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026)
Elanco Animal Health (ELAN) reported Operating Expenses of $494.0 million for Q1 2026, up 11.26% on a YoY basis from $444.0 million in Q1 2025, and down 21.96% sequentially from $633.0 million in Q4 2025.
Elanco Animal Health (ELAN) Operating Expenses (2017 - 2026) Analysis & Trends
Elanco Animal Health (ELAN) has 10 years of Operating Expenses data on file, last reported at $494.0 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 11.26% year-over-year to $494.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (down 34.88% YoY), and the FY2025 full-year result was $2.0 billion, down 48.49% from the prior year.
- Operating Expenses retreated to $494.0 million in Q1 2026, from $633.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $2.2 billion in Q3 2023 to a low of $444.0 million in Q1 2025.
- A 5-year average of $975.1 million and a median of $1.1 billion in 2022 frame the typical range for Operating Expenses.
- Across the five-year window, Operating Expenses surged 102.34% in 2023 and tumbled 78.24% in 2024, its largest moves.
- Tracing ELAN's Operating Expenses over 5 years: stood at $1.1 billion in 2022, then grew by 8.19% to $1.2 billion in 2023, then decreased by 7.83% to $1.1 billion in 2024, then plunged by 40.9% to $633.0 million in 2025, then retreated by 21.96% to $494.0 million in 2026.
- Business Quant data shows ELAN's Operating Expenses at $494.0 million in Q1 2026, $633.0 million in Q4 2025, and $465.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 1.00 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 788.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 12.58 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 455.70 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 1.24 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 621.10 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 494.00 Mn |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 50.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 494.00 Mn |
| Dec 31, 2025 | 633.00 Mn |
| Sep 30, 2025 | 465.00 Mn |
| Jun 30, 2025 | 493.00 Mn |
| Mar 31, 2025 | 444.00 Mn |
| Dec 31, 2024 | 1.07 Bn |
| Sep 30, 2024 | 471.00 Mn |
| Jun 30, 2024 | 1.22 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.16 Bn |
| Sep 30, 2023 | 2.17 Bn |
| Jun 30, 2023 | 1.14 Bn |
| Mar 31, 2023 | 1.15 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.07 Bn |
| Jun 30, 2022 | 1.19 Bn |
| Mar 31, 2022 | 1.15 Bn |
| Dec 31, 2021 | 1.24 Bn |
| Sep 30, 2021 | 1.26 Bn |
| Jun 30, 2021 | 1.52 Bn |